VV

Viney Verma

Active Director Director DIN 08826854
DIN 08826854 First appointment Aug 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value •••• Premium profile

About Viney Verma

Data last updated:

Viney Verma is a Director at Jydem Bio Pharma Private Limited (since 2020). The company operates in Pharma. Jydem Bio Pharma Private Limited reported revenue of ₹83.8 Lakh (FY 2024).

DIN 08826854
Primary Designation Director
Industry Pharma
First Appointment 11 Aug 2020
Oldest Company Age 8 yrs
Largest company Jydem Bio Pharma Private Limited · ₹83.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jydem Bio Pharma Private Limited U74999CH2017PTC041797
Director11 Aug 20202017₹83.8 Lakh (FY 2024)Active

Board colleagues of Viney Verma

NameDINCompanyDesignation
Suresh Mittal01225927Jydem Bio Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Jydem Bio Pharma Private Limited
Premium access

Shareholding and investment profile for Viney Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Viney Verma

Viney Verma currently holds 1 directorship: Jydem Bio Pharma Private Limited (Director, since 11 Aug 2020, revenue ₹83.8 Lakh (FY 2024)).

Viney Verma was first appointed on 11 Aug 2020 as Director at Jydem Bio Pharma Private Limited.

The current boards of Viney Verma's companies include Suresh Mittal (Jydem Bio Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available